Imricor Medical Systems (ASX:IMR) began its official US commercial launch, with the Rady Children's Hospital in San Diego, California, purchasing its NorthStar interventional magnetic resonance (iMR) mapping and guidance system, according to a Monday Australian bourse filing.
It also launched a new vertical, Imricor Cardiovascular, for the NorthStar system. It expects to continue adding devices and applications within the Cardiovascular business over time.
Several US hospitals are in the final stages of the purchasing process, the filing added. Revenue from the NorthStar sales is expected to exceed the European business' aggregate full-year revenue in 2025.